Mohs Surgery for Melanoma in Situ

Dermatologic Clinics

Volumn 29, Issue 2, 2011, Pages 175-183

  Kwon, Soon You ^a   Miller, Stanley J ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Fresh frozen section; Immunostaining; Lentigo maligna; Melanoma in situ; Mohs micrographic surgery; Peripheral margin control; Permanent paraffin section

Indexed keywords

ALPHA INTERFERON; IMIQUIMOD;

ACTINIC KERATOSIS; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BASAL CELL CARCINOMA; CANCER SIZE; CANCER STAGING; CHEMOSURGERY; FOLLOW UP; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT LENTIGO; MELANOMA; MELANOMA IN SITU; MOHS MICROGRAPHIC SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SKIN CANCER; SKIN DEFECT; SUN EXPOSURE; TISSUE FIXATION; TUMOR BIOPSY; VERRUCA VULGARIS;

CARCINOMA IN SITU; HUMANS; MELANOMA; MOHS SURGERY; SKIN NEOPLASMS;

EID: 79952741602     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2011.01.001     Document Type: Review

References (61)

1. Mohs F.E. Chemosurgical treatment of melanoma; a microscopically controlled method of excision. Arch Derm Syphilol 1950, 62(2):269-279.
2. Mohs F.E. Chemosurgery for melanoma. Arch Dermatol 1977, 113(3):285-291.
3. Zitelli J.A., Brown C., Hanusa B.H. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997, 37(2 Pt 1):236-245.
4. Swetter S.M., Boldrick J.C., Jung S.Y., et al. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005, 125(4):685-691.
5. Rhodes A.R. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. Med Clin North Am 1986, 70(1):3-37.
6. Wayte D.M., Helwig E.B. Melanotic freckle of Hutchinson. Cancer 1968, 21(5):893-911.
7. Weinstock M.A., Sober A.J. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987, 116(3):303-310.
8. Cohen L.M. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995, 33(6):923-936. quiz: 37-40.
9. Al-Niaimi F., Jury C.S., McLaughlin S., et al. Review of management and outcome in 65 patients with lentigo maligna. Br J Dermatol 2009, 160(1):211-213.
10. Bosbous M.W., Dzwierzynski W.W., Neuburg M. Staged excision of lentigo maligna and lentigo maligna melanoma: a 10-year experience. Plast Reconstr Surg 2009, 124(6):1947-1955.
11. Bub J.L., Berg D., Slee A., et al. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol 2004, 140(5):552-558.
12. Cohen L.M., McCall M.W., Zax R.H. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg 1998, 24(6):673-677.
13. Hazan C., Dusza S.W., Delgado R., et al. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J Am Acad Dermatol 2008, 58(1):142-148.
14. Huilgol S.C., Selva D., Chen C., et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol 2004, 140(9):1087-1092.
15. Mahoney M.H., Joseph M., Temple C.L. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery. J Surg Oncol 2005, 91(2):120-125.
16. Megahed M., Schon M., Selimovic D., et al. Reliability of diagnosis of melanoma in situ. Lancet 2002, 359(9321):1921-1922.
17. Möller M.G., Pappas-Politis E., Zager J.S., et al. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol 2009, 16(6):1526-1536.
18. Osborne J.E., Hutchinson P.E. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg 2002, 55(8):611-615.
19. Somach S.C., Taira J.W., Pitha J.V., et al. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch Dermatol 1996, 132(11):1297-1302.
20. Zalla M.J., Lim K.K., Dicaudo D.J., et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000, 26(8):771-784.
21. Weedon D. A reappraisal of melanoma in situ. J Dermatol Surg Oncol 1982, 8:774-775.
22. Dawn M.E., Dawn A.G., Miller S.J. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg 2007, 33(4):395-402.
23. Ahlgrimm-Siess V., Massone C., Scope A., et al. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study. Br J Dermatol 2009, 161(6):1307-1316.
24. Ahmed I., Berth-Jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol 2000, 143(4):843-845.
25. Bilu D., Sauder D.N. Imiquimod: modes of action. Br J Dermatol 2003, 149(Suppl 66):5-8.
26. Woodmansee C., Pillow J., Skinner R.B. The role of topical immune response modifiers in skin cancer. Drugs 2006, 66(13):1657-1664.
27. Rajpar S.F., Marsden J.R. Imiquimod in the treatment of lentigo maligna. Br J Dermatol 2006, 155(4):653-656.
28. Cotter M.A., McKenna J.K., Bowen G.M. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol Surg 2008, 34:147-151.
29. Powell A.M., Robson A.M., Russell-Jones R., et al. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. Br J Dermatol 2009, 160(5):994-998.
30. Van Meurs T., Van Doorn R., Kirtschig G. Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients. Dermatol Surg 2010, 36(6):853-858.
31. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Am J Dermatopathol 1993, 15:34-43.
32. Robinson J.K. Margin control for lentigo maligna. J Am Acad Dermatol 1994, 31(1):79-85.
33. Erickson C., Miller S.J. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery. Int J Dermatol 2010, 49(5):482-491.
34. McKenna J.K., Florell S.R., Goldman G.D., et al. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg 2006, 32(4):493-504.
35. Bricca G.M., Brodland D.G., Ren D., et al. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol 2005, 52(1):92-100.
36. Walling H.W., Scupham R.K., Bean A.K., et al. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 2007, 57(4):659-664.
37. Woodmansee C.S., McCall M.W. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatol Surg 2009, 35(8):1286-1289.
38. Weyers W., Bonczkowitz M., Weyers I., et al. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol 1996, 18(6):560-566.
39. Bienert T.N., Trotter M.J., Arlette J.P. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg 2003, 7(1):25-30.
40. Zitelli J.A., Moy R.L., Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991, 24(1):102-106.
41. Bene N.I., Healy C., Coldiron B.M. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol Surg 2008, 34(5):660-664.
42. Barlow R.J., White C.R., Swanson N.A. Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol 2002, 146(2):290-294.
43. Agarwal-Antal N., Bowen G.M., Gerwels J.W. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 2002, 47(5):743-748.
44. Kelley L.C., Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002, 46(1):78-84.
45. Bricca G.M., Brodland D.G., Zitelli J.A. Immunostaining melanoma frozen sections: the 1-hour protocol. Dermatol Surg 2004, 30(3):403-408.
46. Cherpelis B.S., Moore R., Ladd S., et al. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol. Dermatol Surg 2009, 35(2):207-213.
47. Ohsie S.J., Sarantopoulos G.P., Cochran A.J., et al. Immunohistochemical characteristics of melanoma. J Cutan Pathol 2008, 35(5):433-444.
48. El Shabrawi-Caelen L., Kerl H., Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol 2004, 26(5):364-366.
49. Helm K., Findeis-Hosey J. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A. J Cutan Pathol 2008, 35(10):931-934.
50. Albertini J.G., Elston D.M., Libow L.F., et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002, 28(8):656-665.
51. Gross E.A., Andersen W.K., Rogers G.S. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol 1999, 135(1):15-17.
52. Glass L.F., Raziano R.M., Clark G.S., et al. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor. Am J Dermatopathol 2010, 32(4):319-325.
53. Prieto V.G., Argenyi Z.B., Barnhill R.L., et al. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?. Am J Clin Pathol 2003, 120(2):203-208.
54. Johnson T.M., Headington J.T., Baker S.R., et al. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. J Am Acad Dermatol 1997, 37(5 Pt 1):758-764.
55. Clark G.S., Pappas-Politis E.C., Cherpelis B.S., et al. Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control 2008, 15(3):216-224.
56. Stretch J.R., Scolyer R.A. Surgical strategies and histopathologic issues in the management of lentigo maligna. Ann Surg Oncol 2009, 16(6):1456-1458.
57. Bhardwaj S.S., Tope W.D., Lee P.K. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg 2006, 32(5):690-696. [discussion: 696-7].
58. Hill D.C., Gramp A.A. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australas J Dermatol 1999, 40(1):25-30.
59. Clayton B.D., Leshin B., Hitchcock M.G., et al. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 2000, 26(7):671-678.
60. Anderson K.W., Baker S.R., Lowe L., et al. Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. Arch Facial Plast Surg 2001, 3(3):202-206.
61. Then S.Y., Malhotra R., Barlow R., et al. Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma. Dermatol Surg 2009, 35(1):17-23.